Skip to main content

MINI REVIEW article

Front. Immunol.
Sec. Comparative Immunology
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1397780
This article is part of the Research Topic Characterization of the Immune Response to Conventional and Advanced Animal Vaccines View all 6 articles

Defining Correlates of Protection for Mammalian Livestock Vaccines Against High Priority Viral Diseases

Provisionally accepted
  • Australian Centre for Disease Preparedness, CSIRO, Geelong, Victoria, Australia

The final, formatted version of the article will be published soon.

    Enhancing livestock biosecurity is critical to safeguard the livelihoods of farmers, global and local economies, and food security. Vaccination is fundamental to the control and prevention of exotic and endemic high priority infectious livestock diseases. Successful implementation of vaccination in a biosecurity plan is underpinned by a strong understanding of correlates of protectionthose elements of the immune response that can reliably predict the level of protection from viral challenge. While correlates of protection have been successfully characterized for many human viral vaccines, for many high priority livestock viral diseases, including African swine fever and foot and mouth disease, they remain largely uncharacterized. Current literature provides insights into potential correlates of protection that should be assessed during vaccine development for these high priority mammalian livestock viral diseases. Establishment of correlates of protection for biosecurity purposes enables immune surveillance, rationale for vaccine development and successful implementation of livestock vaccines as part of a biosecurity strategy.

    Keywords: correlates of protection, Livestock, biosecurity, Vaccines, protection, Immunity, Antibodies, T cells

    Received: 08 Mar 2024; Accepted: 28 Jun 2024.

    Copyright: © 2024 Davis, Jia, Wright, Islam, Bean, Layton, Williams and Lynch. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Samantha K. Davis, Australian Centre for Disease Preparedness, CSIRO, Geelong, Victoria, Australia

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.